{
    "title": "Eisai, Biogen's new Alzheimer's drug should be priced below Aduhelm - report",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11569407/Eisai-Biogens-new-Alzheimers-drug-priced-Aduhelm--report.html",
    "date": "2022-12-23",
    "keywords": [
        "lecanemab",
        "icer",
        "drug",
        "treatment",
        "report",
        "biogen",
        "aduhelm",
        "price",
        "eisai",
        "side",
        "brain",
        "death",
        "dec",
        "pricing",
        "research",
        "group",
        "co",
        "ltd",
        "draft",
        "institute",
        "review",
        "range",
        "cost",
        "effectiveness",
        "year",
        "person",
        "weight",
        "government",
        "agency",
        "authority",
        "health",
        "account",
        "comment",
        "characterization",
        "analyst",
        "mohit",
        "bansal",
        "rate",
        "decline",
        "dementia",
        "scale",
        "placebo",
        "swelling",
        "bleeding",
        "benefit",
        "possibility",
        "harm",
        "friday",
        "trial",
        "company",
        "cause",
        "reporting",
        "bengaluru",
        "editing",
        "shounak",
        "dasgupta"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}